Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults by Foster, Charlie et al.
                          Foster, C., Grande, A. J., Reid, H., Thomas, E., & Nunan, D. (2016).
Exercise prior to influenza vaccination for limiting influenza incidence and
its related complications in adults. Cochrane Database of Systematic
Reviews, 2015, [CD011857.pub2].
https://doi.org/10.1002/14651858.CD011857.pub2
Publisher's PDF, also known as Version of record
License (if available):
Other
Link to published version (if available):
10.1002/14651858.CD011857.pub2
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Wiley at
https://doi.org/10.1002/14651858.CD011857.pub2 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Cochrane Database of Systematic Reviews
Exercise prior to influenza vaccination for limiting influenza
incidence and its related complications in adults (Review)
Grande AJ, Reid H, Thomas EE, Nunan D, Foster C
Grande AJ, Reid H, Thomas EE, Nunan D, Foster C.
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults.
Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD011857.
DOI: 10.1002/14651858.CD011857.pub2.
www.cochranelibrary.com
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
6BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
14DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
16REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
30DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 1 Blood parameters-
Antibody titre - Follow-up over time. . . . . . . . . . . . . . . . . . . . . . . . . . . 32
Analysis 1.2. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 2 Blood parameters -
Antibody titre - Timing of vaccination. . . . . . . . . . . . . . . . . . . . . . . . . . 33
Analysis 1.3. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 3 Blood parameters -
Antibody titre - Type of exercise. . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
36ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
38APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
43SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
44DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
44INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iExercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Exercise prior to influenza vaccination for limiting influenza
incidence and its related complications in adults
Antonio Jose Grande1, Hamish Reid2, Emma E Thomas2, David Nunan3, Charles Foster4
1Laboratory of Evidence-Based Practice, Universidade do Extremo Sul Catarinense, Criciuma, Brazil. 2British Heart Foundation Centre
on Population Approaches for Non-Communicable Disease Prevention, Nuffield Department of Population Health, University of
Oxford, Oxford, UK. 3Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK. 4British Heart
FoundationCentre on PopulationApproaches for Non-CommunicableDisease Prevention,NuffieldDepartment of PopulationHealth,
University of Oxford, Oxford, UK
Contact address: Antonio Jose Grande, Laboratory of Evidence-Based Practice, Universidade do Extremo Sul Catarinense, Av. Univer-
sitária, 1105, Predio S, LABEPI, Criciuma, Santa Catarina, 88806-000, Brazil. grandeto@gmail.com.
Editorial group: Cochrane Acute Respiratory Infections Group.
Publication status and date: New, published in Issue 8, 2016.
Citation: Grande AJ, Reid H, Thomas EE, Nunan D, Foster C. Exercise prior to influenza vaccination for limiting influenza
incidence and its related complications in adults. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD011857. DOI:
10.1002/14651858.CD011857.pub2.
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Influenza is an infectious virus affecting both humans and animals. In humans, symptoms present as fever, cough, sore throat, runny
nose, headache, muscle and joint pain, and malaise. The epidemiological profile of influenza is influenced by multiple factors, including
transmissibility of the virus and the susceptibility of the population. Annually, influenza is estimated to infect 5% to 10% of adults,
with higher rates in winter seasons in countries with seasonal variation. Exercise could be an intervention to enhance immune response
and limit influenza incidence and its related complications.
Objectives
To assess the efficacy and safety of short and long-term exercise prior to influenza vaccination in enhancing influenza prevention in
adults.
Search methods
We searched CENTRAL (2015, Issue 11), which contains the Cochrane Acute Respiratory Infections Group’s Specialised Register,
MEDLINE (1966 to 3 November 2015), Embase (1974 to 3 November 2015), CINAHL (1981 to 3 November 2015), LILACS (Latin
American and Caribbean Health Sciences, 1982 to 3 November 2015), PEDro (1980 to 3 November 2015), SPORTDiscus (1985 to
3 November 2015), the WHO International Clinical Trials Registry Platform (ICTRP) and ClinicalTrials.gov (November 2015).
Selection criteria
Randomised controlled trials (RCTs) of short- and long-term exercise prior to influenza vaccination for the general adult population
were eligible for inclusion.
Data collection and analysis
Two review authors independently extracted and checked data from the included trials using a standard form. We used the random-
effects model due to differences in the type, duration, intensity and frequency of exercise in the analysis.
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Main results
We included six trials published between 2007 and 2014 that randomised 599 adult participants. Study size ranged from 46 to 158
participants. Participants were aged between 18 years and 80 years; we could not derive gender proportions, as participants’ sex was
not reported in all studies. One study was available in abstract form only.
We did not find a significant difference in outcomes between people who exercised and those who did not exercise before receiving
influenza vaccination.
Pre-vaccination exercises included endurance activities such as walking or using a treadmill, and resistance activities included biceps
curls and lateral raises. Five of the studies provided one session of exercise between 25 and 50 minutes. In five studies, exercise was
undertaken on the same day as the vaccination. One study provided exercise over a period of eight weeks before vaccination, with one
2½ hour supervised session, plus daily home exercise practice of 45 minutes. Exercise intensity ranged from 55% to 85% of maximal
heart rate. Control group participants undertook a range of activities, including quiet rest, sitting, reading, meditation or unspecified
activity.
One study reported numbers of people who contracted influenza; no significant difference was reported between exercise and no-
exercise participants. None of the included studies reported complications related to influenza illness. Only one study, which we assessed
as providing low-quality evidence, reported numbers of people who experienced adverse events. This study reported no significant
difference in outcomes between people who exercised and those who did not. No studies reported numbers of working days or days
lost related to influenza illness. Only two studies reported participant-centred outcomes.
Overall, study quality was unclear; we assessed five of the six included studies to have at least four unclear ’Risk of bias’ domains
(allocation concealment, blinding of outcome assessment, selective reporting and other bias). Insufficient reporting in four studies
about selective reporting did not provide enough information to enable judgement; only two studies were included in trials registers.
Authors’ conclusions
From the available evidence, we found that exercising before influenza vaccination is neither beneficial nor harmful. However, study
data were limited and of low quality. Small sample sizes, study design limitations, exercise types, and focus on biochemical rather than
participant-centred outcomes strongly influenced our findings.
P L A I N L A N G U A G E S U M M A R Y
Can exercising before vaccination reduce numbers of adults who get flu or develop complications?
Review question
We looked at whether exercise before influenza (flu) vaccination can decrease numbers of adults who develop flu and reduce compli-
cations.
Background
Exercise can change immune response. Flu is an infectious virus estimated to affect three to five million people worldwide each year.
Seasonal flu vaccination, which acts on the immune system to protect people from infection, is common in many countries.
Search date
We searched the literature up to November 2015.
Study characteristics
We looked at six studies that involved 599 people aged between 18 and 80 years that assessed exercise before flu vaccination. Exercises
included walking or using a treadmill (endurance) and biceps curls and lateral raises (resistance) activities that ranged from 25 to 50
minutes per session. People in five studies did one session of exercise on the day of vaccination; in one study people exercised eight
weeks before vaccination. Exercise was supervised in three studies. People not undertaking exercise (control group) were assessed after
periods of quiet rest.
Study funding sources
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Three studies did not report study funding sources; one received support from a drug company that donated flu vaccine, one from a
professional society, and another from government agencies.
Key results
We found no differences in numbers of people who caught flu or developed complications between people who exercised and those
who did not before flu vaccination. Only one study reported how many people developed flu after exercise and vaccination. No studies
reported complications related to flu; only one reported adverse events. None reported numbers of working or other days lost due to
flu. No beneficial differences were reported between exercise and no-exercise groups before vaccination.
Small numbers of people who were involved in the studies, limitations in study design, and different exercise types meant we were
unable to draw robust conclusions about any benefits of exercise before vaccination. There appears to be no benefit or harm from
exercising before receiving flu vaccination.
Quality of evidence
Evidence quality was very low or low. More robust study designs that include enough people to enable assessment and analysis of
findings may help to determine if exercise before vaccination can reduce numbers of people who develop flu or complications.
Author’s conclusions
We found that exercising before influenza vaccination is neither beneficial nor harmful. Small number of people in each included study,
many types of exercises, and focus on blood examination instead of participant-centred outcomes strongly influenced our findings.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
Patient or population: Adults and elderly
Setting: Study laboratory
Intervention: Resistance and endurance exercise
Comparison: no exercise
Outcomes Anticipated absolute effects* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk of contracting in-
fluenza - no exercise
before vaccination
Risk of contracting in-
fluenza - exercise be-
fore vaccination
Incidence of influenza
Self -reported inf luenza-
like illness
follow-up: adjusted for
1 year
Median risk in study populat ion RR 0.22
(0.01 to 4.40)
98
(1 study)
⊕⊕©©
very low1,2,3
39 per 1000 9 per 1000
(0 to 172)
Complications related
to inf luenza illness
Not pooled Not pooled Not pooled (no studies) No events in either arm
Adverse events Hyper-
sensit ivity react ion to
vaccinat ion
Median risk in study populat ion Not est imable 120
(1 study)
⊕⊕©©
low¹
No events in either arm
0 per 1000 0 per 1000
(0 to 0)
Numbers of working
days or days lost re-
lated to inf luenza ill-
ness
Not pooled Not pooled Not pooled (no studies) No events in either arm
*The risk in the intervention group (and its 95%CI) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: Conf idence interval; RR: Risk rat io
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GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Lim itat ions in the design and implementat ion. Risk of select ion bias and lack of blinding; allocat ion concealment not
reported.
2Imprecision - wide conf idence intervals.
3Indirectness - self -reported inf luenza-like illness.
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B A C K G R O U N D
Description of the condition
Influenza is an infectious virus affecting both humans and animals.
In humans, symptoms present as fever, cough, sore throat, runny
nose, headache, muscle and joint pain, and malaise (CDC 2009;
WHO 2011). There are three types of influenza: strains: A, B and
C. Influenza A has three subtypes of haemagglutinins (H1, H2
and H3) and two subtypes of neuraminidases (N1 and N2). In-
fluenza B and C are not subdivided. Influenza A has the ability to
make periodic changes to its strain over time, making efficacious
prevention by vaccination a challenge (Demicheli 2014). The epi-
demiological profile of influenza is influenced by several factors,
including transmissibility of the virus and the susceptibility of the
population (CDC 2009; Nair 2011). Influenza is estimated to in-
fect 5% to 10% of adults, with higher rates in winter seasons in
countries with seasonal variation, each year (WHO 2012).
Influenza incidence varies according to age group, with greater
risk observed in children under five years old and adults aged 65
years or over. Priority groups for influenza vaccination are people
with chronic medical conditions and pregnant women, because
these conditions predispose people to influenza-related illness and
hospitalisation (CDC 2010; Molinari 2007).
Influenza is estimated to affect three to five million people world-
wide annually. Economic impact, estimated using a probabilistic
model based on publicly available epidemiological data, is a mean
of USD 87.1 billion per year (Molinari 2007). Costs are predomi-
nantly due to medical care, loss of productivity, life-years lost, and
death (CDC 2010; WHO 2012).
Description of the intervention
Regular exercise has a positive impact on health and is considered
a core behavioural strategy for health promotion (Booth 2012).
For this review we defined exercise as “a planned and structured
programme of motor actions to improve or maintain components
of physical fitness” (Carpersen 1985). Exercise, like administra-
tion of drug therapies, includes components such as frequency,
time, type and intensity (Lobelo 2014). Different types of exercise
provoke different physiological responses (Burton 2004; Edwards
2006).
How the intervention might work
Moderate exercise appears to enhance immune function (Edwards
2007) through the induction of a pro-inflammatory environment
in skeletal muscle, particularly during the eccentric phase of mus-
cle contraction (Peake 2005). Proposed benefits include increased
leukocyte numbers, particularly monocytes and dendritic cells
(Tossige-Gomes 2014), enabling enhanced cell migration to the
antigen exposure site (Krüger 2008). Immune transport is further
aided by augmentation of lymph drainage resulting from muscle
contraction (Schillinger 2006). In contrast, intense exercise may
suppress the immune system, causing increased susceptibility to
infection for the first 24 hours after exercise through a negative ef-
fect on neutrophil phagocytic function and a reduction in natural
killer cell and lymphocyte numbers (Kakanis 2010).Moderate-in-
tensity exercise before intramuscular vaccine administration may
therefore improve the initial immune response to vaccination in
comparison to preceding rest or vigorous muscle activity (Pascoe
2014).
Why it is important to do this review
Despite evidence from Cochrane Reviews showing no impact on
hospitalisation or complication rates (Demicheli 2014; Jefferson
2010; Thomas 2013), influenza vaccination is ingrained in many
public health agendas. These reviews demonstrated a moderate
effect from vaccination on symptom reduction and in decreasing
numbers of working days lost through ill health (Demicheli 2014;
Jefferson 2010; Thomas 2013). We aimed to establish if exercise
before vaccination can enhance efficacy by reducing numbers of
sick days and symptoms caused by influenza, and build upon pre-
vious Cochrane Reviews about influenza vaccination. Numbers of
RCTs supporting exercise before influenza vaccination are growing
(Campbell 2010; Edwards 2006; Edwards 2007; Edwards 2010;
Kohut 2002; Kohut 2004; Ranadive 2014; Woods 2009).
O B J E C T I V E S
To assess the efficacy and safety of short- and long-term exercise
prior to influenza vaccination to enhance influenza prevention in
adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) investigating
exercise before influenza vaccination for the general population.
Cross-over and cluster-RCTs were also eligible for inclusion.
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Types of participants
We included participants randomised to exercise or no exercise
before receiving influenza vaccination. We included no studies
involving children aged up to 18 years.
Types of interventions
We included studies that compared exercise before influenza vacci-
nation with participants who did not exercise before influenza vac-
cination. Exercise could be single or multiple sessions, resistance
or aerobic exercise, specific muscle group or whole-body exercise.
Types of outcome measures
Primary outcomes
1. Incidence of influenza (as reported by primary studies).
2. Complications related to influenza illness.
3. Adverse effects of vaccination.
Secondary outcomes
1. Number of working days or days lost related to influenza
illness.
2. Blood parameters (IgG, IgM, IL-6, etc.).
Search methods for identification of studies
Electronic searches
We searched the Cochrane Central Register of Controlled Trials
(CENTRAL, 2015, Issue 11), which contains theCochrane Acute
Respiratory Infections Group’s Specialised Register, MEDLINE
(1966 to3November 2015), Embase (1974 to 3November 2015),
CINAHL (1981 to 3 November 2015), LILACS (Latin Ameri-
can and Caribbean Health Sciences, 1982 to 3 November 2015),
PEDro (Physiotherapy Evidence Database, 1980 to 3 November
2015) and SPORTDiscus (1985 to 3 November 2015).
We present MEDLINE and Embase search strategies in Appendix
1 and Appendix 2. We combined the MEDLINE search with the
Cochrane Highly Sensitive Search Strategy for identifying ran-
domised trials in MEDLINE (Lefebvre 2011). We adapted the
search strategy to search the other databases. We did not use lan-
guage or publication restrictions. In case of articles in other lan-
guages, we will use academic networks and Cochrane resources to
translate the critical parts to enable screening of abstracts and, if
necessary, critical parts of the full paper.
Searching other resources
We searched the World Health Organization (WHO) Interna-
tional Clinical Trials Registry Platform (apps.who.int/trialsearch/)
and ClinicalTrials.gov for completed and ongoing studies to 3
November 2015. We checked the reference lists of all primary
studies and review articles for additional references. We did not
email experts in the field about other published and unpublished
studies that may be eligible for inclusion.
Data collection and analysis
Selection of studies
Two review authors independently screened all titles and abstracts
identified from searches to determine which met the inclusion
criteria. We retrieved potentially relevant papers in full text. The
same review authors independently screened full-text articles for
inclusion or exclusion, with discrepancies resolved by discussion
and by consulting a third review author where necessary to reach
consensus. We planned to present reports of included studies.
All excluded studies, with reasons for exclusion, are presented in
Characteristics of excluded studies. The study screening and se-
lection process is presented in Figure 1.
Data extraction and management
Two review authors independently extracted data from the in-
cluded studies using a standard data extraction form. We resolved
any discrepancies by discussion until we reached consensus, or
through consultation with a third review author where necessary.
Two review authors extracted data for blood parameters from fig-
ures in four studies (Edwards 2007; Edwards 2010; Long 2012;
Ranadive 2014) to measure themean and standard errors for anal-
ysis and comparison (Silva 2012).
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each in-
cluded study using the ’Risk of bias’ tool published in theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011a).
A third review author resolved any disagreements by discussion.
We assessed risk of bias according to the following domains.
1. Random sequence generation (selection bias). We classified
studies as low risk of bias if they properly described how the
random sequence was generated. We classified them as unclear
risk of bias if they did not provide enough information to be
judged, and as high risk of bias if the randomisation was
conducted in a predictable way.
2. Allocation concealment (selection bias). We classified the
studies as low risk of bias if they properly described how the
allocation was concealed. We classified them as unclear risk of
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bias if they did not provide enough information to be judged,
and as high risk of bias if the allocation was predictable.
3. Blinding of participants and personnel (performance bias).
Due to the characteristics of the intervention (exercise), the
participants could not be blinded.
4. Blinding of outcome assessment (detection bias): Due to
the characteristics of the intervention (exercise), the participants
could not be blinded; however, they could be blinded to the
injection, control group with no vaccine inside.
5. Incomplete outcome data (attrition bias). We classified the
studies as low risk of bias if they properly described data losses or
incomplete data and provided reasons. We classified them as
unclear risk of bias if they did not provide enough information
to be judged. If the studies excluded or omitted analyses of data
outcomes we considered them as high risk of bias.
6. Selective reporting (reporting bias). We classified the studies
as low risk of bias if they properly described what they planned
to do in their project and published all the outcomes planned.
We classified them as unclear risk of bias if they did not provide
enough information to be judged. If the studies reported only
statistically significant findings rather than show the complete
results we considered them high risk of bias.
7. Other bias (other potential sources of bias) related to
particular trial design (cross-over and cluster-randomised) or
specific circumstances such as adjustment of prognostic factors
(e.g. baseline exercise habits, physical fitness).
Measures of treatment effect
Types of measurement of treatment effects that were analysed in-
cluded:
1. Dichotomous data: we used risk ratio (RR) for the binary
outcomes: complications arising from influenza-related illness,
adverse effects of vaccination, and adherence to the group
intervention.
2. Continuous data: we combined results using the mean
difference (MD) for measures that used the same scale, or the
standardised mean difference (SMD) where different scales had
been used to evaluate the same outcome for blood parameters
(antibody titres).
3. Rate: we did not use rate ratio to compare rates between
groups for number of influenza episodes, due to lack of reported
studies.
Unit of analysis issues
We considered individual participants as the unit of analysis.
Among the six included studies, we included one cross-over RCT
and considered only the phase before crossing over interventions.
If cluster-RCTs had been included, we would have made the nec-
essary statistical adjustments for clustering participants.
Dealing with missing data
We did not attempt to contact study authors because we found
no inconsistencies between randomised and analysed study par-
ticipants.
Assessment of heterogeneity
We assessed the inconsistencies between studies using the I² statis-
tic and described the percentage of variability in effect. We con-
sidered heterogeneity substantial if I² statistic was over 50%.
Assessment of reporting biases
We identified nomismatches between study protocols and reports.
We had planned to assess the impact of including such studies by
conducting a sensitivity analysis. We did not perform a funnel plot
asymmetry test, as we only included six trials.
Data synthesis
Meta-analysis of the included RCTs was possible only for partici-
pants’ blood parameters. We used a random-effects model, inde-
pendently of the heterogeneity identified. When it was not possi-
ble to pool data, we present narrative analyses of individual stud-
ies.
GRADE and ’Summary of findings’ table
We created a ’Summary of findings’ table using the following out-
comes: incidence of influenza, complications related to influenza
illness, adverse events, and numbers of working days or days lost
related to influenza illness. We used the five GRADE considera-
tions (Atkins 2004): study limitations, consistency of effect, im-
precision, indirectness and publication bias, to assess the qual-
ity of a body of evidence as it relates to the studies which con-
tribute data to the meta-analyses for the prespecified outcomes.
We used methods and recommendations described in Section 8.5
and Chapter 12 of theCochraneHandbook for Systematic Reviews of
Interventions (Higgins 2011b), using GRADEproGDT software
(GRADEproGDT 2015). We justified all decisions to down- or
upgrade the quality of studies using footnotes, and we made com-
ments to aid readers’ understanding of the review where necessary.
Subgroup analysis and investigation of heterogeneity
We conducted subset analyses for blood parameters antibody titre:
1. follow-up over time;
2. timing of vaccination; and
3. type of exercise.
Sensitivity analysis
We pooled studies to verify if the impact of risk of bias affected
the overall treatment effect of exercising. We also assessed which
studies contributed to heterogeneity.
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R E S U L T S
Description of studies
Results of the search
Our search identified 485 records from databases, handsearches
of reference lists, grey literature and trial register search results.
We removed 68 duplicate records (n = 317 records). Two review
authors then assessed titles and abstracts and deleted 305 records
that did not match inclusion criteria. We obtained full-text copies
of the remaining 12 potentially relevant references. Of these, six
studies did not meet inclusion criteria. See Figure 1.
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Figure 1. Study flow diagram
Included studies
We included six trials that randomised 599 adult participants,
published between 2007 and 2014 in English language (Edwards
2007; Edwards 2010; Edwards 2013; Hayney 2014; Long 2012;
Ranadive 2014). Edwards 2013 was available as an abstract only.
(See Included studies; Table 1; Table 2).
Design
Five included studies were parallel RCTs (Edwards 2007; Edwards
2010; Edwards 2013; Hayney 2014; Long 2012); Ranadive 2014
was a randomised, cross-over design.
Sample sizes
The included studies randomised 599 adult participants. Sample
size ranged from 46 participants (Edwards 2013) to 158 partici-
pants (Edwards 2010).
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Setting
All included trials were single-centre studies: two were conducted
in the USA (Hayney 2014; Ranadive 2014) and four in the UK
(Edwards 2007; Edwards 2010; Edwards 2013; Long 2012).
Participants
Participants were aged from 18 years to 80 years. Proportions
of women ranged from 50% to 82%. One study did not report
participants’ gender (Long 2012).
Interventions
Pre-vaccination exercises included endurance activities such as
walking or using a treadmill, and resistance activities including
biceps curls and lateral raises. Five studies included one exercise
session of between 25 minutes and 50 minutes on the same day
as the vaccination (Edwards 2007; Edwards 2010; Edwards 2013;
Long 2012; Ranadive 2014). Hayney 2014 provided exercise over
a period of eight weeks before vaccination, with one 2½-hour su-
pervised session, plus daily home exercise practice of 45 minutes.
Exercise intensity ranged from 55% to 85% of maximal heart rate.
Control group participants undertook a range of activities includ-
ing quiet rest, sitting, reading or no exercise.
Outcomes
Hayney 2014 reported numbers of people who contracted in-
fluenza; no significant difference was reported between exercise
andno-exercise participants.None of the included studies reported
complications related to influenza illness.
Long 2012 reported numbers of people who experienced adverse
events. This study reported no significant difference in outcomes
between people who exercised and those who did not.
No studies reported numbers of working days or days lost related
to influenza illness.
Excluded studies
We excluded six studies.Of these, four were not RCTs, and two did
notmatch our inclusion criteria because control group participants
also undertook exercise (see Characteristics of excluded studies).
Risk of bias in included studies
Figure 2 and Figure 3 are graphic presentations of risk of bias’
assessments. The overall quality of the studies was unclear, since
five of the six included studies had at least four unclear risk of
bias domains (allocation concealment, blinding of outcome assess-
ment, selective reporting and other bias). Insufficient information
in four studies about selective reporting did not allow judgement
(Edwards 2007; Edwards 2010; Edwards 2013; Ranadive 2014),
as only two studies were included in trials registers (Hayney 2014;
Long 2012).
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Allocation
Three studies appropriately described randomisation procedures
(Edwards 2007; Edwards 2013; Hayney 2014), two studies did
not provide sufficient information to enable assessment (Long
2012; Ranadive 2014), and one study was classified as high risk of
bias: “Participants were pseudo-randomised, maintaining an even
sex distribution” (Edwards 2010). For allocation concealment, we
classified five studies as unclear risk of bias since they did not
provide sufficient information to enable assessment. We assessed
only one study at low risk of bias, because investigators used codes
provided in concealed envelopes, which were opened after consent
to indicate allocation (Hayney 2014).
Blinding
We considered five studies at high risk of bias for blinding partic-
ipants and personnel, since the nature of the study interventions
(exercise) meant that blinding of participants was not possible.
However, Ranadive 2014 was considered low risk of bias because
personnel were blinded by using sham vaccination. Considering
detection bias and blinding of outcome assessment, five studies did
not provide sufficient information to enable assessment; Hayney
2014 blinded laboratory staff performing the haemagglutination
inhibition assay (HIA) to participant status. Only one study used
a placebo vaccination.
Incomplete outcome data
We classified five studies (Edwards 2007; Edwards 2010; Hayney
2014; Long 2012; Ranadive 2014) at low risk of bias, since losses
to follow-up were less than 10% for the antibody titre analysed in
each study; these studies also provided adequate data analysis in
relation to losses to follow-up. We rated one study at unclear risk
of bias because of insufficient information to enable judgement
about exclusions, and no reporting of missing data. This study was
available in abstract form only (Edwards 2013).
Selective reporting
Only two studies registered their trials before conducting the study.
We found no differences between the protocols and the study
reports, and classified both at low risk of bias (Hayney 2014; Long
2012).We classified the remaining four included studies at unclear
risk of bias, because of insufficient information to enable outcome
assessment (antibody titre) from different timepoints or analysis
across study follow-up.
Other potential sources of bias
We considered one study to be at high risk of bias due to baseline
imbalance of older people, either sedentary or physically active,
since the authors did not control for physical activity level in the
analysis (Ranadive 2014).
Three studies did not report study funding sources; one received
support from a drug company that donated flu vaccine, one from
a professional society, and another from government agencies.
Effects of interventions
See: Summary of findings for the main comparison Resistance
and endurance exercise prior to influenza vaccination versus no
exercise prior to influenza vaccination
Incidence of influenza
Hayney 2014 reported no significant difference between exercise
and non-exercise groups in relation to influenza incidence (risk ra-
tio (RR) 0.22, 95% confidence interval (CI) 0.01 to 4.40, partic-
ipants = 98). We rated the evidence quality as very low (Summary
of findings for the main comparison).
Complications related to influenza illness
None of the included studies reported data about complications
relating to influenza.
Adverse events associated with vaccination
Long 2012 (120 participants) reported adverse events associated
with vaccination; none were reported in the influenza vaccination
and non-vaccination groups. We assessed evidence quality as low
(Summary of findings for the main comparison).
Numbers of working days or days lost related to
influenza illness
None of the included studies reported data on numbers of working
days or days lost related to influenza illness.
Blood parameters
Five studies reported blood parameters (Edwards 2007; Edwards
2010; Hayney 2014; Long 2012; Ranadive 2014). We conducted
subset analyses for antibody titres of viral strains A and B for fol-
low-up over time (Analysis 1.1), vaccination timing (Analysis 1.2)
and exercise type (Analysis 1.3). We assessed the evidence quality
as low due to lack of information about study design and imple-
mentation (risk of selection bias and lack of blinding, allocation
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concealment) not being adequately reported in most studies; we
also found imprecision, indicated by wide confidence intervals.
Antibody titre - follow-up over time
Up to six weeks follow-up after vaccination
We found no significant difference between exercise and no-exer-
cise study arm participants (five studies, 490 participants; strain
A: standardised mean difference (SMD) -0.05, 95% CI -0.28 to
0.18, Analysis 1.1.1; Chi² test 5.97; df = 4; P = 0.20; I² statistic
33%. Strain B: SMD -0.11, 95% CI -0.29 to 0.08, Analysis 1.1.2;
Tau² = 0.00, Chi² test 0.88, df = 4, P = 0.93; I² statistic 0%).
Over 6 weeks follow-up after vaccination
We found no significant difference between exercise and no-ex-
ercise participants (two studies, 155 participants; strain A: SMD
0.09, 95% CI -0.23 to 0.41, Analysis 1.1.3; Tau² = 0.00; Chi² test
0.04, df = 1, P = 0.83, I² statistic 0%. strain B: SMD -0.23, 95%
CI -0.70 to 0.25, Analysis 1.1.4; Tau² = 0.06; Chi² test 2.00, df =
1, P = 0.16, I² statistic 50%).
Antibody titre - vaccination timing
Five studies contributed data to this outcome. We analysed data
in six subsets (Analysis 1.2).
Antibody titres viral strains A and B - Exercise immediately
prior to vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (four studies, 392 participants; strain
A: SMD -0.14, 95%CI -0.35 to 0.07; Analysis 1.2.1; Tau² = 0.00;
Chi² test 2.70, df = 3, P = 0.44, I² statistic 0%. Strain B: SMD
-0.14, 95% CI -0.36 to 0.07; Analysis 1.2.2; Tau² = 0.00; Chi²
test 0.39, df = 3, P = 0.94, I² statistic 0%).
Antibody titres viral strains A and B - Exercise immediately
prior to vaccination - over six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 57 participants; strain A:
SMD 0.14, 95% CI -0.41 to 0.68; Analysis 1.2.3. Strain B: SMD
-0.51, 95% CI -1.07 to 0.04; Analysis 1.2.4).
Antibody titres viral strains A and B - Vaccination after six
weeks of exercise
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 98 participants; strain A:
SMD 0.06, 95% CI -0.33 to 0.46; Analysis 1.2.5. Strain B: SMD
-0.02, 95% CI -0.42 to 0.37; Analysis 1.2.6).
Antibody titre - exercise type
We identified five relevant studies and categorised data into eight
subsets (Analysis 1.3).
Antibody titres viral strains A and B - Resistance exercise
prior to vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (two studies, 217 participants; strain
A: SMD 0.01, 95% CI -0.29 to 0.31, Analysis 1.3.1; Tau² = 0.00;
Chi² test 0.87, df = 1, P = 0.35, I² statistic 0%. Strain B: SMD
-0.08, 95% CI -0.38 to 0.22, Analysis 1.3.2; Tau² = 0.00; Chi²
test 0.05, df = 1, P value 0.82, I² statistic 0%).
Antibody titres viral strains A and B - Endurance exercise
prior to vaccination - up to six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (two studies, 175 participants; strain
A: SMD -0.28, 95%CI -0.58 to 0.02, Analysis 1.3.3; Tau² = 0.00;
Chi² test 0.02, df = 1, P = 0.89, I² statistic 0%. Strain B: SMD
-0.21, 95% CI -0.50 to 0.09, Analysis 1.3.4; Tau² = 0.00; Chi²
test 0.01, df = 1, P = 0.94, I² statistic 0%).
Antibody titres viral strains A and B - Resistance exercise
immediately prior to vaccination - over six weeks follow-up
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 57 participants; strain A:
SMD 0.14, 95% CI -0.41 to 0.68, Analysis 1.3.5. Strain B: SMD
-0.51, 95% CI -1.07 to 0.04, Analysis 1.3.6).
Antibody titres viral strains A and B - Endurance exercise for
eight weeks then vaccination
We found no significant difference between exercise and no-exer-
cise study arm participants (one study, 98 participants; strain A:
SMD 0.06, 95% CI -0.33 to 0.46, Analysis 1.3.7. Strain B: SMD
-0.02, 95% CI -0.42 to 0.37, Analysis 1.3.8).
D I S C U S S I O N
Summary of main results
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We aimed to assess the efficacy and safety of short- and long-
term exercise prior to influenza vaccination to enhance influenza
prevention in adults.
We did not find significant differences for any outcomes between
people who exercised and those who did not before influenza vac-
cination. Only one study reported influenza incidence; none in-
vestigated complications related to influenza illness; and one study
reported adverse events. No included studies investigated numbers
of working days or days lost related to influenza; five studies re-
ported blood parameter data. We reported data for several subsets:
antibody titre follow-up over time and according to exercise type.
We pooled effects of antibody titre post-intervention. Only two
studies reported participant-centred outcomes; all studies planned
to investigate blood parameters to identify immunological reason-
ing to support the use of exercise prior to influenza vaccination.
Overall, we assessed study quality as low.
We analysed findings from six RCTs that compared exercise versus
no exercise before and immediately before influenza vaccination
and found:
• Influenza incidence was slightly lower in the exercise group;
however, data came from only one study assessed as providing
very low-quality evidence.
• No adverse events were reported for either exercise or no-
exercise participant groups; however, data came from only one
study assessed as providing low-quality evidence.
• The standardised mean difference (SMD) in the
intervention group for blood parameters was 0.05 units lower
(range -0.28 to +0.18) in serum antibody titres of viral strain A.
Data for this outcome came from five studies.
• The SMD in the intervention group for blood parameters
was 0.11 units lower (range -0.29 to +0.08) in serum antibody
titres of viral strain B. Data for this outcome came from five
studies.
Overall completeness and applicability of
evidence
We found that exercise before influenza vaccination did not im-
prove protection provided by influenza vaccination. We assessed
the current evidence as low quality, due to imprecision and high
risk of bias. Given the small body of evidence, and the relative
novelty of the concept that exercise before vaccination could in-
fluence outcomes, it may be too soon to draw further conclusions.
Different types of exercise and intensity of physical effort were not
widely considered by the included studies and may confer differ-
ent physiological adaptations, either beneficial or harmful.
It is also important to highlight that study data were limited in
terms of numbers of outcomes reported; most did not assess par-
ticipant-centred outcomes. Most studies investigated immunolog-
ical outcomes to assess the hypothesis that exercise can improve
efficacy and reduce complications related to influenza vaccination.
The applicability of evidence to clinical practice remains uncertain.
Quality of the evidence
The overall quality of evidence was low. We based this assessment
on lack of blinding and risk of selection bias (allocation conceal-
ment not reported in the studies), and imprecision, with small
sample sizes and wide confidence intervals. We found a high risk
of bias for blinding of participants and personnel, and reporting
deficits in at least four domains for five of the six included studies.
Randomisation sequence generation was not clearly described in
Long 2012 and Edwards 2013; these studies applied pseudo-ran-
domisation.
The nature of the exercise interventions investigated meant that
it was not possible to blind participants. Sham vaccination was
used inRanadive 2014.While outcome assessors could be blinded,
only Hayney 2014 provided sufficient information to confirm
that blinding was carried out. Attrition bias was not a concern
in most studies; only Edwards 2013 was unclear regarding this
domain, although only Long 2012 and Ranadive 2014 provided
appropriate methods (e.g. intention-to-treat analysis) for dealing
with missing data and dropouts. Four studies were not listed in
trials registers (Edwards 2007; Edwards 2010; Edwards 2013;
Ranadive 2014).
Potential biases in the review process
We followed recommendations made for study selection, data col-
lection, and data analysis provided in the Cochrane Handbook for
Systematic Reviews of Interventions in this review (Higgins 2011b).
The strengths of the review process were numbers of databases
searched and search sensitivity to detect all potentially relevant
studies.
Review limitations were that too few studies were included to as-
sess for publication bias by constructing funnel plots; poor study
reporting meant that we could not assess some ’Risk of bias’ do-
mains; and we found an absence of participant-centred outcome
data in the included RCTs.
Agreements and disagreements with other
studies or reviews
Pascoe 2014 conducted a systematic review about vaccination pro-
grammes for influenza, meningococcus, tetanus, keyhole limpet
haemocyanin (KLH) and pneumococcus to observe the effects of
exercise on immune response prior to vaccination. The authors
included 20 studies that applied RCT, cross-sectional and obser-
vational study designs. The evidence presented by Pascoe 2014
showed that exercise significantly improved immune response to
vaccination. The authors used the “Assessingmethodological qual-
ity of systematic review reviews (AMSTAR)” instrument to assess
data quality (good quality, 8 out of a possible 11 points). How-
ever, there were some limitations in Pascoe 2014: the quality of the
included studies was not assessed and documented; the scientific
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quality of the included studies was not appropriately applied in
formulating conclusions; results were not pooled for assessment.
Our review focused on exercise before influenza vaccination, and
we have improved on the work presented by Pascoe 2014. We
reported synthesis and assessment of the evidence, documented
assessment of study quality, and provided conclusions based on
our findings.
We found no differences in benefits or harms from exercise before
influenza vaccination. A possible reason could be that the included
studies did not adjust for baseline characteristics according to the
physical activity levels of each participant, so that the dose-re-
sponse of exercising before influenza vaccination could have been
diluted in the results.
Analysis of the published evidence about exercise before influenza
vaccination demonstrated that exercise in its many types and in-
tensities did not provide either additional benefit or harm before
influenza vaccination.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We were unable to determine if exercise before influenza vaccina-
tion is effective for reducing influenza incidence, complications
related to influenza illness, adverse events or blood parameter out-
comes. We rated the quality of the evidence as low or very low;
there is significant uncertainty around benefits or harms of exer-
cise before influenza vaccination.
Implications for research
The biological plausibility of how exercise functions influence
health outcomes remains unclear, and exercise mechanisms should
be further explored. Exercise type, intensity, duration and fre-
quency are challenging to estimate to derive beneficial levels before
influenza vaccination. We suggest that researchers designing fu-
ture studies should investigate participant-focused outcomes such
as influenza incidence, complications related to influenza illness,
and adverse events. It is also essential to adequately describe and
report study design, results and outcomes that are relevant to pub-
lic health objectives and agendas.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Edwards 2007
Methods AIMS ANDOBJECTIVES To compare the effects of eccentric exercise on the immune
response in men and women
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION from December 2004 to an unspecified
date
STUDY DURATION 20 weeks
SETTING, NUMBER OF CENTRES University of Birmingham, UK; single centre
Participants INCLUSION CRITERIA Physically active students
EXCLUSION CRITERIA
“None of the participants had received the influenza vaccine in the past year, or reported
influenza in the winter prior to participation. None of the participants smoked, had a
history of immune or cardiovascular disease, were suffering from an acute infection or
illness, were pregnant, were currently taking medication (except birth control), or had
a history of vaccine-related allergies or side-effects. All participants were instructed to
abstain from vigorous exercise for at least 24 hours, alcohol for at least 12 hours, caffeine
for at least 2 hours, and food for at least 1 hour prior to testing. In addition, none of the
participants had performed any regular resistance training in the past 6 months.”
RECRUITMENT
N SCREENED 60 students N RANDOMISED 60 students N COMPLETED 57
students
N INTERVENTION GROUP 40 students N CONTROL GROUP 20 students
GENDER 29 men; 31 women
AGEMen = 20.1 years (SD 1.64 years); Women = 20.6 years (SD 2.55 years)
Interventions DESCRIPTION OF INTERVENTION
“Eccentric portions of the biceps curl and lateral raise exercises, contracting the biceps
brachii and deltoid muscles of the non-dominant arm. The weights used were 85% of
each participant’s single repetition concentric maxima which had been determined 1
week earlier. All participants performed 50 repetitions of each contraction (6 sets of 7
repetitions followed by 2 sets of 4 repetitions). They completed a set of lateral raises,
rested 30 seconds, completed a set of biceps curls, and rested 60 seconds before the next
set of lateral raises. The task lasted approximately 25 min.”
DELIVERY An investigator tracked each movement
COMPARATOR GROUP Remained resting quietly, reading for 25 minutes
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Blood samples, haemagglutination inhi-
bition test, cell-mediated antigen-specific immunity, limb circumference and pain, stress
DETAILS OF ALL GROUPS
Exercise group: allocated n = 40, analysed at 6 weeks n = 38, analysed at 8 weeks n =
35, analysed at 20 weeks n = 37
Control group: allocated n = 20, analysed at 6 weeks n = 19, analysed at 8 weeks n =
19, analysed at 20 weeks n = 20
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Edwards 2007 (Continued)
FOLLOW-UP PERIOD 6 week, 8 week and 20 week points
Notes TRIAL REGISTRATION Not registered
ETHICS All participants gave written informed consent and the study was approved by
the South Birmingham Local Research Ethics Committee
FUNDING Influenza vaccines donated by GlaxoSmithKline, UK
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Participants were allocated on a 2:1 ratio
to either the exercise (N = 40) or control (N
= 20) groups, based on a pre-determined
restricted random assignment to force an
unequal sample size schedule”
Allocation concealment (selection bias) Unclear risk No information provided. We assumed
that participants and investigators could
not foresee assignment prior to allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blind to exercise or
control
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7.5% dropout in the exercise group. No
intention-to-treat used
Selective reporting (reporting bias) Unclear risk Outcomes proposed in theMethods are re-
ported in the results. However, study pro-
tocol was not registered
Other bias Low risk None found
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Edwards 2010
Methods AIMS AND OBJECTIVES
“To investigate whether exercise augmented the immune response to a reduced dose
vaccine, and whether the intensity of exercise influenced the efficacy of the intervention.
”
“To compare the efficacy of a relatively low (60% of concentric one repetition maximum
(1 RM)), medium (85% 1 RM), and high (110% 1 RM) intensity eccentric exercise
intervention”
STUDY DESIGN RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 28 days
SETTING, NUMBER OF CENTRES University of Birmingham, UK. Single centre
Participants INCLUSION CRITERIA Not reported
EXCLUSION CRITERIA
“Smoking, a history of immune or cardiovascular disease, current acute infection or
illness, pregnancy or suspected pregnancy, and a history of vaccine-related allergies or
side effects. Use of prescription medication within 1 month of participation was also
an important exclusion criterion; but females taking the contraceptive pill were not
excluded. In addition, none of the participants reported having performed any resistance
training in the 6 months prior to testing.”
RECRUITMENT
N SCREENED 160 participants N RANDOMISED 158 participants N COM-
PLETED 158 participants
INTERVENTION A 40 studentsINTERVENTION B 40 studentsINTERVENTION
C 40 studentsCONTROL 40 students
GENDER (completed study) 78 men; 80 women
AGE 20.5 ± 1.6 years
Interventions DESCRIPTION OF INTERVENTION
“Eccentric portions of the biceps curl and lateral raise exercises, contracting the biceps
brachii and deltoid muscles of the non-dominant arm. The weights used were 85% of
each participant’s single repetition concentric maxima which had been determined 1
week earlier. All participants performed 50 repetitions of each contraction (6 sets of 7
repetitions followed by 2 sets of 4 repetitions). They completed a set of lateral raises,
rested 30 seconds, completed a set of biceps curls, and rested 60 seconds before the next
set of lateral raises. The task lasted approximately 25 minutes.”
DELIVERY An investigator tracked each movement
CONTROL GROUP Quiet rest for 25 minutes
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES
Blood samples, haemagglutination inhibition test, cell-mediated antigen-specific immu-
nity, limb circumference, pain, stress, CK and IL-6
GROUP ALLOCATION
Exercise group 60% of the concentric one repetition maxima (1RM): allocated n = 40,
analysed at 28 days n = 40
Exercise group 85% of the concentric one repetition maxima (1RM): allocated n = 40,
analysed at 28 days n = 40
Exercise group 110% of the concentric one repetition maxima (1RM): allocated n = 40,
analysed at 28 days n = 39
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Edwards 2010 (Continued)
Control group: allocated n = 40, analysed at 28 days n = 39, analysed at 8 weeks n = 19,
analysed at 20 week n = 20
FOLLOW-UP PERIOD 28 days
Notes TRIAL REGISTRATION No registry
ETHICS Participants provided written informed consent; study protocol approved by
the Black Country Local Research Ethics Committee
FUNDING Not reported
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Participants were pseudo-randomised,
maintaining an even sex distribution”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blind to exercise or
control
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% dropout
Selective reporting (reporting bias) Unclear risk The outcomes proposed in the Methods
were reported in the Results. However,
study protocol was not registered
Other bias Low risk None found
Edwards 2013
Methods CONFERENCE ABSTRACT
AIMS AND OBJECTIVES “To investigate the effects of exercise immediately prior to
influenza vaccination on immune responses”
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 1 month
SETTING, NUMBER OF CENTRES Not reported
Participants INCLUSION CRITERIA Not reported
EXCLUSION CRITERIA Not reported
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Edwards 2013 (Continued)
RECRUITMENT
N SCREENED 46 participants N RANDOMISED 46 participants N COMPLETED
46 participants
GENDER 23 men; 23 women
AGEMean age = 73 ± 7 years
Interventions DESCRIPTION OF INTERVENTION
The exercise group performed 50mins of resistance exercises using upper and lower body
muscle groups at an intensity of 60% of predetermined 1 repetition maximum (1RM)
DELIVERY Not reported
COMPARATOR GROUP Quiet reading
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Changes in inflammatory markers
GROUP ALLOCATION
Exercise group: allocated n = 23, analysed at 1 month not reported
Control group: allocated n = 23, analysed at 1 month not reported
FOLLOW-UP PERIOD 1 month
Notes TRIAL REGISTRATION Not reported
ETHICS Not reported
FUNDING Not reported
CONFLICTS OF INTEREST Not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomly assigned to complete a control
(quiet reading) or exercise task...”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blind to exercise or
control
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information provided
Selective reporting (reporting bias) Unclear risk No study protocol was registered
Other bias Low risk None found
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Hayney 2014
Methods AIMS AND OBJECTIVES To compare influenza vaccine responses due to meditation
or exercise training with controls
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION June 2012 to June 2016
STUDY DURATION 20 weeks
SETTING,NUMBEROFCENTRESUniversity ofWisconsinHealth SportsMedicine
Center; single centre
Participants INCLUSION CRITERIA Participants aged 50 years or older, willing to undertake any
of the 3 randomisation outcomes, and reporting either 2 or more colds in the last 12
months or an average of 1 or more colds per year
EXCLUSION CRITERIA “...previous training or current practice of meditation, mod-
erate exercise at least 2 times a week or vigorous exercise at least 1 time a week, and a
score of less than 24 points on the Folstein Mini-Mental State Examination or more
than 14 points on the 9-item Patient Health Questionnaire (PHQ-9) depression screen;
immunodeficiency, autoimmune, or malignant disease; or prior allergic reaction to in-
fluenza vaccine or egg allergy.”
RECRUITMENT
N RANDOMISED 154 participants N COMPLETED 149 participants
GENDER 21 men, 133 women
AGEMean age 59.26 ± 8.87 years
Interventions DESCRIPTION OF INTERVENTION “The exercise program was designed and led
by exercise physiologist at was matched to the meditation program in terms of duration
(8 weeks), contact time (weekly 2.5 hour group sessions), home practice (45 min per
day), and location. Borg’s Rating of Perceived Exertion was used to guide participants
toward moderate intensity, sustained exercise, with a target rating of 12 to 16 points on
the 6-to-20 point scale.”
DELIVERY Senior exercise physiology staff
CONTROL GROUPWait-list control
Outcomes PRESPECIFIEDOUTCOMEMEASURES Influenza antibody responses post-immu-
nisation; Seroprotection at least 160 HA U and measures of well-being
GROUP ALLOCATION Exercise: 47 participants; Meditation: 51 participants; Con-
trol: 51 participants
FOLLOW-UP PERIOD 3 months
Notes TRIAL REGISTRATION NCT01057771
ETHICS Not reported
FUNDINGSupported by a grant from theNational Institutes ofHealth (NIH),National
Center for Complementary and Alternative Medicine (1R01AT004313); and by a grant
UL1RR025011 from the Clinical and Translational Science Award (CTSA) Program of
the National Center for Research Resources, National Institutes of Health. Aleksandra
Zgierska is supported by grant K23AA017508 fromNational Institute on Alcohol Abuse
and Alcoholism at NIH
CONFLICTS OF INTEREST Bruce Barrett was previously supported by career devel-
opment grants from the National Center for Complementary and Alternative Medicine
(K23AT00051) and from the Robert Wood Johnson Foundation, both of which were
essential for developing the methodology and infrastructure for recruiting and monitor-
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Hayney 2014 (Continued)
ing research subjects, and for assessing their acute respiratory infections
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “SAS software was used to generate 165
unique identification numbers in balanced
blocks of 3”
Allocation concealment (selection bias) Low risk “Codes were concealed envelopes, which
were opened after consent to indicate allo-
cation”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blind to exercise or
control
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk “The laboratory staff performing the HIA
used the standard micro titre techniques
and was blinded to participant status”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 3% dropout
Selective reporting (reporting bias) Low risk Outcomes proposed in the protocol were
included in published results
Other bias Low risk None found
Long 2012
Methods AIMS AND OBJECTIVES To compare the responses of a young and older participant
cohort to determine if the efficacy of this intervention differs between the age groups
STUDY DESIGN Parallel RCT
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 1 month
SETTING, NUMBER OF CENTRES University of Birmingham, UK and the West
Midlands area. Centre/s not specified
Participants INCLUSION CRITERIA “Either 18-30 or 50-64 years old; not highly endurance
trained; no vaccination against influenza in the previous year or pneumonia in the last
10 years; no allergy to egg or chicken proteins; no latex allergy; no history of cancer,
inflammatory disease or cardiovascular disease; no chronic obstructive pulmonary disor-
der, diabetes mellitus, asthma, congestive heart failure, Guillain Barre syndrome or psy-
chiatric disorder; no females who were pregnant or breastfeeding; no current infection;
and no medication or medical condition which may influence immune function”
EXCLUSION CRITERIA Not reported
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Long 2012 (Continued)
RECRUITMENT West Midlands area via local newspapers, flyers, email and Internet
advertisements, local community group visits, and by word of mouth
N SCREENED 161 participants N RANDOMISED 122 participants N COM-
PLETED 120 participants
GENDER Not reported
AGE 18 to 30 years cohort; 50 to 64 years cohort
Interventions SETTING OF INTERVENTION
Participants attended the laboratory on 2 separate occasions, 1 month apart
DESCRIPTION OF INTERVENTION
“Participants in the intervention group wore a heart rate monitor throughout the walk;
average heart rate was used as a marker of physical activity intensity. After completing
a warm-up lap and a series of lower body isometric muscle stretches, participants were
instructed to walk at a brisk pace for 45 min around a specified route while maintaining
their heart rate at or above 55% of their heart rate maximum, calculated as 220 minus
age. The walking route included sections of uphill and downhill walking to elicit both
concentric and eccentric contractions of the muscles. After the intervention, participants
carried out a cool down involving isometric muscle stretches.”
DELIVERY Not reported
CONTROL GROUP Sat quietly in the laboratory for 45 minutes prior to receiving the
vaccinations
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Health behaviours, IgG and IgM pneu-
mococcal, influenza antibody titres, cardiac responses to intervention
GROUP ALLOCATIONS Exercise group: allocated n = 60, analysed at 4 weeks n =
60; Control group: allocated n = 60, analysed at 4 weeks n = 60
FOLLOW-UP PERIOD 4 weeks
Notes TRIAL REGISTRATION Not reported
ETHICS All participants gave written informed consent and the study was approved by
the South Birmingham Local Research Ethics Committee
FUNDING Not reported
CONFLICTS OF INTEREST No conflicts of interest declared
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “randomised into two groups, with an
equal number of males and females in each
group”
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants were not blind to exercise or
control
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Long 2012 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1% dropout rate
Selective reporting (reporting bias) Low risk The outcomes proposed in the Methods
are reported in the Results. However, study
protocol was not registered
Other bias Low risk None found
Ranadive 2014
Methods AIMS AND OBJECTIVES
“To evaluate the effect of acute moderate aerobic exercise immediately before adminis-
tration of the influenza vaccine on antibody titres and seroprotective responses in older
adults. To investigate whether acute exercise immediately before influenza vaccination
produces different effects on antibody response in older men versus older women.”
STUDY DESIGN Randomised, counterbalanced, cross-over design
DATES OF STUDY IMPLEMENTATION Not known
STUDY DURATION 6 weeks
SETTING, NUMBER OF CENTRES University of Illinois at Urbana-Champaign
Participants INCLUSION CRITERIA “All subjects were free from cardiovascular or respiratory
disease, and none smoked. A stress test was performed on visit 1 to exclude any participant
with evidence of stress-induced ischaemia”
EXCLUSION CRITERIA “Participants were excluded if they had metabolic disease
(diabetes mellitus), inflammatory diseases (rheumatoid arthritis and systemic lupus ery-
thematosus), or bleeding disorder; were taking medications known to affect inflamma-
tion (aspirin); and had a history of smoking (any form). Participants who had suffered
from common cold or influenza and bacterial or viral infection or upper respiratory tract
infection 2 months preceding testing were also excluded. Participants who had already
received influenza vaccination for the season or who were taking thyroid medication or
allergy medication on a regular basis were excluded as well. Participants were also ex-
cluded if they were taking over-the-counter pain/anti-inflammatory medication during
the course of the study.”
RECRUITMENT All participants were recruited from the local community and pro-
vided written informed consent before participation
N SCREENED 59 participants N RANDOMISED 59 participants N COMPLETED
55 participants
GENDER (completed) 23 men, 32 women
AGE 66.5 ± 0.8 years
Interventions SETTING Temperature-controlled room
DESCRIPTIONOF INTERVENTIONExercise groupperformed a40-minmoderate-
intensity aerobic exercise bout at an intensity of 55% to 65% of their maximum HR
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Ranadive 2014 (Continued)
immediately preceding the vaccination and sham injection
DELIVERY Not reported
COMPARATOR GROUP Non-exercise group did not perform physical activity pre-
ceding vaccination; received sham injection
CO-INTERVENTIONS None
Outcomes PRESPECIFIED OUTCOME MEASURES Influenza antibody titres, anthropomet-
rics, brachial blood pressure, hemagglutination inhibition titre, inflammatory markers
GROUP ALLOCATIONS Exercise group: allocated n = 30, analysed at 4 weeks n =
29; Control group: allocated n = 29, analysed at 4 weeks n = 27
FOLLOW-UP PERIOD 4 weeks
Notes TRIAL REGISTRATION Not registered
ETHICS Approved by the Institutional Review Board of the University of Illinois at
Urbana-Champaign
FUNDING Authors thanked the American Heart Association for the 2-yr pre-doctoral
fellowship (no. 10PRE3500083)
CONFLICTS OF INTEREST The authors declared no conflicts of interest
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “...randomised to an acute exercise or to a
non-exercise group”. Method of randomi-
sation not reported
Allocation concealment (selection bias) Unclear risk No information provided
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk “The participant and the researchers were
blinded to when they received the vaccine
or sham injection”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No information provided
Incomplete outcome data (attrition bias)
All outcomes
Low risk 7% dropout rate
Selective reporting (reporting bias) Unclear risk The outcomes proposed in theMethods are
reported in the Results. However, no study
protocol was registered
Other bias High risk “...the cohort included older individuals
who are sedentary as well as physically ac-
tive and did not control it”
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Abbreviations: HIA - hemagglutination inhibition assay; HR - heart rate; IgG - immunoglobulin G; IgM - immunoglobulin M; IL -
interleukin; RM - repetition maximum; SD - standard deviation
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Hara 2002 Not RCT. Study analysed physical activity level as an outcome
Kohut 2002 Not RCT. Study included a control group but randomisation was not conducted
Kohut 2004 RCT. Control group had participants exercising (low intensity) and participants not exercising together in the
control group
Whitham 2003 Not RCT. Heavy versus light exercise training groups. No non-exercise group
Woods 2009 RCT. Control group participants engaged in low intensity exercise
Yang 2007 Not RCT. Study included a control group but randomisation was not conducted
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D A T A A N D A N A L Y S E S
Comparison 1. Exercise versus no exercise prior to influenza vaccination
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Blood parameters- Antibody
titre - Follow-up over time
5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
1.1 Antibody titres viral strain
A - up to 6 weeks follow-up
after vaccination
5 490 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.28, 0.18]
1.2 Antibody titres viral strain
B - up to 6 weeks follow-up
after vaccination
5 490 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.29, 0.08]
1.3 Antibody titres viral strain
A - over 6 weeks follow-up after
vaccination
2 155 Std. Mean Difference (IV, Random, 95% CI) 0.09 [-0.23, 0.41]
1.4 Antibody titres viral strain
B - over 6 weeks follow-up after
vaccination
2 155 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.70, 0.25]
2 Blood parameters - Antibody
titre - Timing of vaccination
5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
2.1 Antibody titres viral strain
A - Exercise immediately prior
to vaccination - up to 6 weeks
follow-up
4 392 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.35, 0.07]
2.2 Antibody titres viral strain
B - Exercise immediately prior
to vaccination - up to 6 weeks
follow-up
4 392 Std. Mean Difference (IV, Random, 95% CI) -0.14 [-0.36, 0.07]
2.3 Antibody titres viral strain
A - Exercise immediately prior
to vaccination - over 6 weeks
follow-up
1 57 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.41, 0.68]
2.4 Antibody titres viral strain
B - Exercise immediately prior
to vaccination - over 6 weeks
follow-up
1 57 Std. Mean Difference (IV, Random, 95% CI) -0.51 [-1.07, 0.04]
2.5 Antibody titres viral strain
A - Vaccination after 6 weeks of
exercise
1 98 Std. Mean Difference (IV, Random, 95% CI) 0.06 [-0.33, 0.46]
2.6 Antibody titres viral strain
B - Vaccination after 6 weeks of
exercise
1 98 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.42, 0.37]
3 Blood parameters - Antibody
titre - Type of exercise
5 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
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3.1 Antibody titres viral strain
A - Resistance exercise prior to
vaccination - up to 6 weeks
follow-up
2 217 Std. Mean Difference (IV, Random, 95% CI) 0.01 [-0.29, 0.31]
3.2 Antibody titres viral strain
B - Resistance exercise prior to
vaccination - up to 6 weeks
follow-up
2 217 Std. Mean Difference (IV, Random, 95% CI) -0.08 [-0.38, 0.22]
3.3 Antibody titres viral strain
A - Endurance exercise prior to
vaccination - up to 6 weeks
follow-up
2 175 Std. Mean Difference (IV, Random, 95% CI) -0.28 [-0.58, 0.02]
3.4 Antibody titres viral strain
B - Endurance exercise prior to
vaccination - up to 6 weeks
follow-up
2 175 Std. Mean Difference (IV, Random, 95% CI) -0.21 [-0.50, 0.09]
3.5 Antibody titres viral
strain A - Resistance exercise
immediately prior to
vaccination - over 6 weeks
follow-up
1 57 Std. Mean Difference (IV, Random, 95% CI) 0.14 [-0.41, 0.68]
3.6 Antibody titres viral
strain B - Resistance exercise
immediately prior to
vaccination - over 6 weeks
follow-up
1 57 Std. Mean Difference (IV, Random, 95% CI) -0.51 [-1.07, 0.04]
3.7 Antibody titres viral strain
A - Endurance exercise for 8
weeks then vaccination
1 98 Std. Mean Difference (IV, Random, 95% CI) 0.06 [-0.33, 0.46]
3.8 Antibody titres viral strain
B - Endurance exercise for 8
weeks then vaccination
1 98 Std. Mean Difference (IV, Random, 95% CI) -0.02 [-0.42, 0.37]
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Analysis 1.1. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 1 Blood
parameters- Antibody titre - Follow-up over time.
Review: Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
Comparison: 1 Exercise versus no exercise prior to influenza vaccination
Outcome: 1 Blood parameters- Antibody titre - Follow-up over time
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Antibody titres viral strain A - up to 6 weeks follow-up after vaccination
Edwards 2007 38 1.92 (1.3562) 19 2.17 (0.6538) 13.7 % -0.21 [ -0.76, 0.34 ]
Edwards 2010 120 242.5 (237.8211) 40 218.5 (220.4108) 25.0 % 0.10 [ -0.26, 0.46 ]
Hayney 2014 47 149.8 (37.2262) 51 139.9 (33.2076) 21.9 % 0.28 [ -0.12, 0.68 ]
Long 2012 60 3.7 (0.5422) 60 3.85 (0.4648) 24.8 % -0.30 [ -0.65, 0.06 ]
Ranadive 2014 28 3 (1.5875) 27 3.4 (1.5588) 14.6 % -0.25 [ -0.78, 0.28 ]
Subtotal (95% CI) 293 197 100.0 % -0.05 [ -0.28, 0.18 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 5.97, df = 4 (P = 0.20); I2 =33%
Test for overall effect: Z = 0.44 (P = 0.66)
2 Antibody titres viral strain B - up to 6 weeks follow-up after vaccination
Edwards 2007 38 1.8 (12.9453) 19 2.1 (0.741) 11.5 % -0.03 [ -0.58, 0.52 ]
Edwards 2010 120 1152 (685.9677) 40 1220 (544.0382) 27.1 % -0.10 [ -0.46, 0.25 ]
Hayney 2014 47 55.8 (28.1082) 51 53.5 (188.5337) 22.1 % 0.02 [ -0.38, 0.41 ]
Long 2012 60 2.75 (0.9295) 60 2.95 (0.9295) 27.0 % -0.21 [ -0.57, 0.15 ]
Ranadive 2014 28 2.5 (2.1166) 27 2.9 (2.0785) 12.4 % -0.19 [ -0.72, 0.34 ]
Subtotal (95% CI) 293 197 100.0 % -0.11 [ -0.29, 0.08 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 4 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 1.14 (P = 0.25)
3 Antibody titres viral strain A - over 6 weeks follow-up after vaccination
Edwards 2007 37 1.25 (0.6691) 20 1.17 (0.3578) 34.6 % 0.14 [ -0.41, 0.68 ]
Hayney 2014 47 107.35 (33.2499) 51 105.2 (33.4219) 65.4 % 0.06 [ -0.33, 0.46 ]
Subtotal (95% CI) 84 71 100.0 % 0.09 [ -0.23, 0.41 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
4 Antibody titres viral strain B - over 6 weeks follow-up after vaccination
Edwards 2007 37 0.9 (0.7908) 20 1.25 (0.3578) 42.0 % -0.51 [ -1.07, 0.04 ]
Hayney 2014 47 46.6 (26.8742) 51 47.2 (28.4943) 58.0 % -0.02 [ -0.42, 0.37 ]
Subtotal (95% CI) 84 71 100.0 % -0.23 [ -0.70, 0.25 ]
-1 -0.5 0 0.5 1
Exercise Non-exercise
(Continued . . . )
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(. . . Continued)
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Heterogeneity: Tau2 = 0.06; Chi2 = 2.00, df = 1 (P = 0.16); I2 =50%
Test for overall effect: Z = 0.94 (P = 0.35)
Test for subgroup differences: Chi2 = 1.55, df = 3 (P = 0.67), I2 =0.0%
-1 -0.5 0 0.5 1
Exercise Non-exercise
Analysis 1.2. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 2 Blood
parameters - Antibody titre - Timing of vaccination.
Review: Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
Comparison: 1 Exercise versus no exercise prior to influenza vaccination
Outcome: 2 Blood parameters - Antibody titre - Timing of vaccination
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Antibody titres viral strain A - Exercise immediately prior to vaccination - up to 6 weeks follow-up
Edwards 2007 38 1.92 (1.3562) 19 2.17 (0.6538) 14.7 % -0.21 [ -0.76, 0.34 ]
Edwards 2010 120 242.5 (237.8211) 40 218.5 (220.4108) 34.9 % 0.10 [ -0.26, 0.46 ]
Long 2012 60 3.7 (0.5422) 60 3.85 (0.4648) 34.5 % -0.30 [ -0.65, 0.06 ]
Ranadive 2014 28 3 (1.5875) 27 3.4 (1.5588) 15.9 % -0.25 [ -0.78, 0.28 ]
Subtotal (95% CI) 246 146 100.0 % -0.14 [ -0.35, 0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.70, df = 3 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.27 (P = 0.20)
2 Antibody titres viral strain B - Exercise immediately prior to vaccination - up to 6 weeks follow-up
Edwards 2007 38 1.8 (12.9453) 19 2.1 (0.741) 14.7 % -0.03 [ -0.58, 0.52 ]
Edwards 2010 120 1152 (685.9677) 40 1220 (544.0382) 34.8 % -0.10 [ -0.46, 0.25 ]
Long 2012 60 2.75 (0.9295) 60 2.95 (0.9295) 34.6 % -0.21 [ -0.57, 0.15 ]
Ranadive 2014 28 2.5 (2.1166) 27 2.9 (2.0785) 15.9 % -0.19 [ -0.72, 0.34 ]
-2 -1 0 1 2
Exercise Non-exercise
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(. . . Continued)
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 246 146 100.0 % -0.14 [ -0.36, 0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.39, df = 3 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.34 (P = 0.18)
3 Antibody titres viral strain A - Exercise immediately prior to vaccination - over 6 weeks follow-up
Edwards 2007 37 1.25 (0.6691) 20 1.17 (0.3578) 100.0 % 0.14 [ -0.41, 0.68 ]
Subtotal (95% CI) 37 20 100.0 % 0.14 [ -0.41, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.49 (P = 0.62)
4 Antibody titres viral strain B - Exercise immediately prior to vaccination - over 6 weeks follow-up
Edwards 2007 37 0.9 (0.7908) 20 1.25 (0.3578) 100.0 % -0.51 [ -1.07, 0.04 ]
Subtotal (95% CI) 37 20 100.0 % -0.51 [ -1.07, 0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.069)
5 Antibody titres viral strain A - Vaccination after 6 weeks of exercise
Hayney 2014 47 107.35 (33.2499) 51 105.2 (33.4219) 100.0 % 0.06 [ -0.33, 0.46 ]
Subtotal (95% CI) 47 51 100.0 % 0.06 [ -0.33, 0.46 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
6 Antibody titres viral strain B - Vaccination after 6 weeks of exercise
Hayney 2014 47 46.6 (26.8742) 51 47.2 (28.4943) 100.0 % -0.02 [ -0.42, 0.37 ]
Subtotal (95% CI) 47 51 100.0 % -0.02 [ -0.42, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.92)
-2 -1 0 1 2
Exercise Non-exercise
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Analysis 1.3. Comparison 1 Exercise versus no exercise prior to influenza vaccination, Outcome 3 Blood
parameters - Antibody titre - Type of exercise.
Review: Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults
Comparison: 1 Exercise versus no exercise prior to influenza vaccination
Outcome: 3 Blood parameters - Antibody titre - Type of exercise
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Antibody titres viral strain A - Resistance exercise prior to vaccination - up to 6 weeks follow-up
Edwards 2007 38 1.92 (1.3562) 19 2.17 (0.6538) 29.6 % -0.21 [ -0.76, 0.34 ]
Edwards 2010 120 242.5 (237.8211) 40 218.5 (220.4108) 70.4 % 0.10 [ -0.26, 0.46 ]
Subtotal (95% CI) 158 59 100.0 % 0.01 [ -0.29, 0.31 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.87, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 0.06 (P = 0.95)
2 Antibody titres viral strain B - Resistance exercise prior to vaccination - up to 6 weeks follow-up
Edwards 2007 38 1.8 (12.9453) 19 2.1 (0.741) 29.7 % -0.03 [ -0.58, 0.52 ]
Edwards 2010 120 1152 (685.9677) 40 1220 (544.0382) 70.3 % -0.10 [ -0.46, 0.25 ]
Subtotal (95% CI) 158 59 100.0 % -0.08 [ -0.38, 0.22 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
3 Antibody titres viral strain A - Endurance exercise prior to vaccination - up to 6 weeks follow-up
Long 2012 60 3.7 (0.5422) 60 3.85 (0.4648) 68.5 % -0.30 [ -0.65, 0.06 ]
Ranadive 2014 28 3 (1.5875) 27 3.4 (1.5588) 31.5 % -0.25 [ -0.78, 0.28 ]
Subtotal (95% CI) 88 87 100.0 % -0.28 [ -0.58, 0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.85 (P = 0.064)
4 Antibody titres viral strain B - Endurance exercise prior to vaccination - up to 6 weeks follow-up
Long 2012 60 2.75 (0.9295) 60 2.95 (0.9295) 68.6 % -0.21 [ -0.57, 0.15 ]
Ranadive 2014 28 2.5 (2.1166) 27 2.9 (2.0785) 31.4 % -0.19 [ -0.72, 0.34 ]
Subtotal (95% CI) 88 87 100.0 % -0.21 [ -0.50, 0.09 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.36 (P = 0.17)
5 Antibody titres viral strain A - Resistance exercise immediately prior to vaccination - over 6 weeks follow-up
Edwards 2007 37 1.25 (0.6691) 20 1.17 (0.3578) 100.0 % 0.14 [ -0.41, 0.68 ]
Subtotal (95% CI) 37 20 100.0 % 0.14 [ -0.41, 0.68 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.49 (P = 0.62)
6 Antibody titres viral strain B - Resistance exercise immediately prior to vaccination - over 6 weeks follow-up
-2 -1 0 1 2
Exercise Non-exercise
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(. . . Continued)
Study or subgroup Exercise Non-exercise
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Edwards 2007 37 0.9 (0.7908) 20 1.25 (0.3578) 100.0 % -0.51 [ -1.07, 0.04 ]
Subtotal (95% CI) 37 20 100.0 % -0.51 [ -1.07, 0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.82 (P = 0.069)
7 Antibody titres viral strain A - Endurance exercise for 8 weeks then vaccination
Hayney 2014 47 107.35 (33.2499) 51 105.2 (33.4219) 100.0 % 0.06 [ -0.33, 0.46 ]
Subtotal (95% CI) 47 51 100.0 % 0.06 [ -0.33, 0.46 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
8 Antibody titres viral strain B - Endurance exercise for 8 weeks then vaccination
Hayney 2014 47 46.6 (26.8742) 51 47.2 (28.4943) 100.0 % -0.02 [ -0.42, 0.37 ]
Subtotal (95% CI) 47 51 100.0 % -0.02 [ -0.42, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.92)
-2 -1 0 1 2
Exercise Non-exercise
A D D I T I O N A L T A B L E S
Table 1. Included study participant characteristics at baseline
Study name/location Participants
randomised/withdrew
% women Age Participant characteristics
Edwards 2007
UK
60/3 51% 20.35 ± 2.09 years Physically active students
Edwards 2010
UK
160/2 51% 20.5 ± 1.6 years Mean BMI = 21.6 ± 2.6 kg/m²
Edwards 2013
UK (Abstract only)
46/0 50% 73 ± 7 years Mean BMI = 27.20 ± 5 kg/m²
Hayney 2014
USA
154/5 81.8% 50 years and over Healthy, sedentary
Long 2012
UK
122/2 NR 18 to 30 years cohort;
50 to 64 years cohort
Mean BMI = 24.50 ± 4.23 kg/
m²
Mean BMI = 25.97 ± 4.12 kg/
m²
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Table 1. Included study participant characteristics at baseline (Continued)
Ranadive 2014
USA
59/4 54% 66.5 ± 0.85 Mean BMI = 25.55 ± 0.9 kg/
m²
Abbreviations: BMI - body mass index; NR - not reported
Table 2. Characteristics of exercise intervention and timing of influenza vaccination
ID
Study lo-
cation/s
Exercise
type
Frequency Intensity Duration Supervi-
sion
Control
group
Timing of
Influenza
vaccina-
tion
Partic-
ipant fol-
low-up
Outcomes
in meta-
analysis
Edwards
2007
UK
Biceps curl
and lateral
raise
1 session 85% of 1
RM
25 min (6
sets of 7
repetitions
and 2 sets
of 4 repeti-
tions)
Supervised Quiet rest-
ing
Exer-
cise imme-
diately be-
fore vacci-
nation
6, 8, 20
weeks
post-vacci-
nation
Adverse ef-
fects;
blood pa-
rameters
Edwards
2010
UK
Non-dom-
inant arm
biceps curl
and lateral
raise
1 session 60% of 1
RM; 85%
of 1 RM;
110% of 1
RM
25min (10
sets
of 5 repeti-
tions)
Supervised Quiet rest-
ing
Exer-
cise imme-
diately be-
fore vacci-
nation
4 weeks
post-vacci-
nation
Adverse ef-
fects;
blood pa-
rameters
Edwards
2013
UK
Resistance
upper and
lower body
1 session 60% of 1
RM
50minutes NR Quiet
reading
Exer-
cise imme-
diately be-
fore vacci-
nation
4 weeks
post-vacci-
nation
None
Hayney
2014
USA
Bicycle,
treadmill
and brisk
walk
1 week ses-
sion (2½
hours) +
45minutes
daily home
practice
12 to
16 Borg
scale
8 weeks 1 week ses-
sion super-
vised
by exercise
physiolo-
gist
Medita-
tion
and no ex-
ercise
6 months
after exer-
cise
12 weeks
post-vacci-
nation
In-
cidence of
influenza;
number
of working
days
lost; blood
parameters
Long 2012
UK
Walk 1 session 55%
MHR
45minutes No super-
vision
Quiet sit-
ting
Exer-
cise imme-
diately be-
fore vacci-
nation
4 weeks
post-vacci-
nation
Adverse ef-
fects;
blood pa-
rameters
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Table 2. Characteristics of exercise intervention and timing of influenza vaccination (Continued)
Ranadive
2014
USA
Aerobic
exercise
1 session 55% to
65%
MHR
40minutes NR NR Exer-
cise imme-
diately be-
fore vacci-
nation
4 weeks
post-vacci-
nation
Blood pa-
rameters
Abbreviations: HRR - heart rate reserve; ID - identification; MHR -maximum heart rate; NR - not reported; RM - repetition maximum
A P P E N D I C E S
Appendix 1. MEDLINE (OVID)
1 exp INFLUENZA/
2 influenza.mp.
3 or/1-2
4 exp VACCINES/
5 exp VACCINATION/
6 (immuniz$ or immunis$).mp.
7 vaccin$.mp.
8 or/4-7
9 3 and 8
10 exp Influenza Vaccine/
11 (influenz$ adj (vaccin$ or immun$)).mp.
12 or/10-11
13 9 or 12
14 exp Exercise/
15 exp Exercise Movement Techniques/
16 exp Exercise Therapy/
17 Physical Fitness/
18 physical endurance/ or exercise tolerance/
19 Physical Exertion/
20 exp Sports/
21 Dancing/
22 (exercis* or sport* or fitness* or gym* or aerobic*).tw.
23 ((weight* or strength* or enduranc* or circuit*) adj5 (program* or train* or session*)).tw.
24 (physical* adj5 (fit* or activ* or movement* or train* or condition* or program*)).tw.
25 (activ* adj2 life*).tw.
26 (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or
qi gong).tw.
27 or/14-26
28 13 and 27
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Appendix 2. Embase search strategy
#23 #11 AND #22
#22 #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21
#21 run*:ab,ti OR walk*:ab,ti OR jog*:ab,ti OR sprint*:ab,ti OR treadmill*:ab,ti OR row*:ab,ti OR swim*:ab,ti OR bicycl*:ab,ti OR
cycl*:ab,ti OR danc*:ab,ti OR yoga:ab,ti OR ’tai chi’:ab,ti OR ’tai ji’:ab,ti OR qigong:ab,ti OR ’qi gong’:ab,ti AND [embase]/lim
#20 (activ* NEAR/2 life*):ab,ti AND [embase]/lim
#19 (physical* NEAR/5 (fit* OR activ* OR movement* OR train* OR condition* OR program*)):ab,ti AND [embase]/lim
#18 ((weight* OR strength* OR enduranc* OR circuit*) NEAR/5 (program* OR train* OR session*)):ab,ti AND [embase]/lim
#17exercis*:ab,ti OR sport*:ab,ti OR fitness*:ab,ti OR gym*:ab,ti OR aerobic*:ab,ti AND [embase]/lim
#16 ’sport’/exp AND [embase]/lim
#15 ’training’/de OR ’endurance’/de OR ’exercise tolerance’/de OR ’physical capacity’/de AND [embase]/lim
#14 ’physical activity’/exp OR ’physical activity, capacity and performance’/de AND [embase]/lim
#13 ’kinesiotherapy’/exp AND [embase]/lim
#12 ’exercise’/exp AND [embase]/lim
#11 #1 OR #10
#10 #5 AND #9
#9 #6 OR #7 OR #8
#8 immuniz*:ab,ti OR immunis*:ab,ti
#7 ’immunization’/exp
#6 ’vaccine’/exp OR ’vaccination’/de
#5 #2 OR #3 OR #4
#4 ’influenza virus a’/exp OR ’influenza virus b’/de
#3 influenza*:ab,ti OR flu:ab,ti
#2 ’influenza’/exp
#1 ’influenza vaccine’/de
Appendix 3. CINAHL search strategy
S38 S28 AND S37
S37 S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36
S36 (MH “Quantitative Studies”)
S35 TI placebo* OR AB placebo*
S34 (MH “Placebos”)
S33 TI random* OR AB random*
S32 TI ((singl* or doubl* or tripl* or trebl*) W1 (blind* or mask*)) OR AB ((singl* or doubl* or tripl* or trebl*)W1 (blind* or mask*))
S31 TI clinic* W1 trial* OR AB clinic* W1 trial*
S30 PT clinical trial
S29 (MH “Clinical Trials+”)
S28 S14 AND S27
S27 S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26
S26 TI (run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong
or qi gong) OR AB (run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong)
S25 TI activ* N5 life* OR AB activ* N5 life*
S24 TI (physical* N5 (fit* or activ* or movement* or train* or condition* or program*)) OR AB (physical* N5 (fit* or activ* or
movement* or train* or condition* or program*))
S23 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*)) ORAB ((weight* or strength* or enduranc*
or circuit*) N5 (program* or train* or session*))
S22 TI (exercis* or sport* or fitness* or gym* or aerobic*) OR AB (exercis* or sport* or fitness* or gym* or aerobic*)
S21 (MH “Dancing+”)
S20 (MH “Sports+”)
S19 (MH “Exertion”) OR (MH “Exercise Intensity”)
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S18 (MH “Physical Endurance+”)
S17 (MH “Physical Fitness+”)
S16 (MH “Therapeutic Exercise+”)
S15 (MH “Exercise+”)
S14 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13
S13 TI (ari or urti or lrti) OR AB (ari or urti or lrti)
S12 TI (bronchit* or pneumon* or bronchopneumon* or pleuropneumon*) OR AB (bronchit* or pneumon* or bronchopneumon*
or pleuropneumon*)
S11 TI (sinusit* or rhinosinusit* or nasosinusit*) OR AB (sinusit* or rhinosinusit* or nasosinusit*)
S10 TI cough* OR AB cough*
S9 (MH “Cough”)
S8 TI (nasopharyngit* or rhinopharyngit*) OR AB (nasopharyngit* or rhinopharyngit*)
S7 TI (throat* N3 (infect* or inflam*)) OR AB (throat* N3 (infect* or inflam*))
S6 TI (pharyngit* or laryngit* or tonsillit* or sore throat*) OR AB (pharyngit* or laryngit* or tonsillit* or sore thoat*)
S5 TI (influenza* or flu or ili) OR AB (influenza* or flu or ili)
S4 TI ((acute or viral or virus* or bacter*) N2 rhinit*) OR AB ((acute or viral or virus* or bacter*) N2 rhinit*)
S3 TI (common cold* or colds or coryza) OR AB (common cold* or colds or coryza)
S2 TI (respiratory N2 (infect* or illness or symptom* or acute or virus*)) OR AB (respiratory N2 (infect* or illness or symptom* or
acute or virus*))
S1 (MH “Respiratory Tract Infections”) OR (MH “Bronchitis”) OR (MH “Bronchitis, Acute”) OR (MH “Common Cold”) OR (MH
“Influenza”) OR (MH “Influenza, Human”) OR (MH “Influenza, Seasonal”) OR (MH “Laryngitis”) OR (MH “Pharyngitis”) OR
(MH “Pneumonia+”) OR (MH “Sinusitis+”) OR (MH “Tonsillitis”)
Appendix 4. LILACS search strategy
MH:“Respiratory Tract Infections” OR “Upper Respiratory Tract Infections” OR MH:C01.539.739$ OR MH:C08.730$ OR
MH:Bronchitis OR MH:C08.127.446$ OR MH:C08.381.495.146 OR MH:C08.730.099 OR MH:“Common Cold” OR MH:
C02.782.687.207$ OR MH:C08.730.162$ OR “Cold, Common” OR “Coryza, Acute” OR MH:“Influenza, Human” OR MH:
C02.782.620.365$ OR MH:C08.730.310$ OR Grippe OR “Human Flu” OR “Human Influenza” OR “Influenza in Hu-
mans” OR MH:Laryngitis OR MH:C08.360.535 OR MH:C08.730.368 OR MH:C09.400.535 OR MH:Pharyngitis OR MH:
C07.550.781$ OR MH:C08.730.561$ OR MH:C09.775.649$ OR “Sore Throat” OR MH:C08.381.677$ OR MH:08.730.610$
OR “Experimental Lung Inflammation” OR “Lobar Pneumonia” OR “Lung Inflammation” OR “Pulmonary Inflammation”
OR MH:Sinusitis OR MH:C08.460.692.752$ OR MH:C08.730.749$ OR MH:C09.603.692.752$ OR MH:Nasopharyngitis
OR MH:C07.550.350.700$ OR MH:C07.550.781.500$ OR MH:C08.730.561.500$ OR MH:C09.775.350.700$ OR MH:
C09.775.649.500$ ORMH:Cough ORMH:Tos ORMH:Tosse ORMH:C08.618.248$ MH:C23.888.852.293$ ORMH:Bronchi-
tis OR MH:Bronquitis OR MH:Bronquite OR MH:C08.127.446$ OR MH:C08.381.495.146$ OR MH:C08.730.099$ OR MH:
Bronconeumonía ORMH:C08.127.509$ ORMH:C08.381.677.127$ ORMH:C08.730.610.127$ ORMH:Pleuropneumonia OR
MH:C08.381.677.473$ OR MH:C08.528.735.473$ OR MH:C08.730.582.473$ OR MH:C08.730.610.473$ AND MH:Exercise
OR “Aerobic Exercise” OR “Exercise, Aerobic” OR “Exercise, Isometric” OR “Exercise, Physical” OR “Isometric Exercise” OR MH:
G11.427.590.530.698.277$ OR MH:I03.350$ OR MH:“Exercise Movement Techniques” OR MH:“Exercise Therapy” OR OR
MH:E02.779.483$ ORMH:E02.831.387$ ORMH:“Physical Fitness” OR “Physical Conditioning, Human” ORMH:I03.621$ OR
MH:N01.400.545$ OR MH:“Physical Endurance” OR MH:G11.427.680$ OR MH:I03.450.642.845.054.600$ OR MH:“Exer-
cise Tolerance” OR MH:G11.427.680.270$ OR MH: “Physical Exertion” OR “Physical Effort” OR MH:G11.427.590.780$ OR
MH:Sports OR Athletics OR MH:I03.450.642.845$ OR MH:Dancing OR MH:I03.450.642.287$ OR MH:Gymnastics OR Cal-
isthenics OR MH:I02.233.543.454$ OR MH:I03.450.642.845.417$ OR MH:“Weight Lifting” OR MH:I03.450.642.845.950$
OR MH:“Muscle Strength” OR MH:E01.370.600.425$ OR MH:G11.427.560$ OR MH: “Physical Education and Training” OR
MH:I02.233.543$ OR MH:Running OR MH:G11.427.590.530.568.610$ OR MH:G11.427.590.530.698.277.750$ OR MH:
I03.450.642.845.610$ OR MH:Jogging OR MH:G11.427.590.530.568.610.320$ OR MH:G11.427.590.530.698.277.750.320$
OR MH:I03.450.642.845.610.320$ OR MH: “Exercise Test” OR Bicycle OR “Ergometry Test” OR “Arm Ergometry Test” OR
“Step Test” OR “Stress Test” OR “Treadmill Test” OR MH:E01.370.370.380.250$ OR MH:E01.370.386.700.250$ OR MH:
E05.333.250$ OR “Prueba Ergométrica de Bicicleta” OR “Test Ergométrico de Bicicleta” OR MH:Swimming OR Natación
OR Natação OR MH:G11.427.590.530.568.800$ OR MH:G11.427.590.530.698.277.875$ OR MH:I03.450.642.845.869$ OR
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MH:Bicycling OR MH:I03.450.642.845.140$ OR MH:Yoga OR MH:E02.190.525.937$ OR MH:E02.190.901.984$ OR MH:
E02.779.474.937$ ORMH:K01.844.799.867$ ORMH:“Tai Ji” ORMH:E02.190.525.890$ ORMH:E02.779.474.913$ ORMH:
I03.450.642.845.560.500$ OR MH:“Breathing Exercises” OR “Ch’i Kung” OR “Qi Gong” OR Qigong OR “Respiratory Muscle
Training” OR MH:E02.190.525.186$ OR MH:E02.779.474.124$ OR “Ch’i Kung” OR “Qi Gong” OR Qigong
Appendix 5. PEDro search strategy
exercise AND vaccination
Appendix 6. SPORTDiscus search strategy
S40 S33 AND S39
S39 S34 OR S35 OR S36 OR S37 OR S38 OR S39
S38 TI ( crossover* or cross over* ) OR AB ( crossover* or cross over* )
S37 TI ( (singl* or doubl*) W1 (blind* or mask*) ) OR AB ( (singl* or doubl*) W1 (blind* or mask*) )
S36 TI trial
S35 TI clinic* W1 trial* OR AB clinic* W1 trial*
S34 TI placebo* OR AB placebo*
S33 TI random* OR AB random*
S32 S19 AND S31
S31 S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30
S30 TI ( run* or walk* or jog* or sprint* or treadmill* or row* or swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong
or qi gong ) OR AB ( run* or walk* or jog* or sprint* or treadmill* or row* or
swim* or bicycl* or cycl* or danc* or yoga or tai chi or tai ji or qigong or qi gong )
S39 TI activ* N2 life* OR AB activ* N2 life*
S28 TI ( physical* N5 (fit* or activ* or movement* or train* or condition* or program*) ) OR AB ( physical* N5 (fit* or activ* or
movement* or train* or condition* or program*) )
S27 TI ( (weight* or strength* or enduranc* or circuit*) N5 (program* or train* or session*) ) OR AB ( (weight* or strength* or
enduranc* or circuit*) N5 (program* or train* or session*) )
S26 TI ( exercis* or sport* or fitness* or gym* or aerobic* ) OR AB ( exercis* or sport* or fitness* or gym* or aerobic* )
S25DE “DANCE”ORDE “AERIAL dance” ORDE “AEROBIC dancing” ORDE “AFRICANAmerican dance”ORDE “BALLET”
ORDE “BALLROOM dancing” ORDE “BELLY dance” ORDE “BREAK dancing” ORDE “CHA-cha (Dance)” ORDE “COUN-
TRY dancing” OR DE “DANCE for people with disabilities” OR DE “FLAMENCO” OR DE “FOLK dancing” OR DE “FREE
skating” OR DE “HIP-hop dance” OR DE “ICE dancing” OR DE “JAZZ dance” OR DE “LINE dancing” OR DE “LION dance”
OR DE “MODERN dance” OR DE “MOVEMENT notation” OR DE “ORIGINAL set pattern dance (Skating)” OR DE “POLE
dancing” OR DE “ROUND dancing” OR DE “SALSA (Dance)” OR DE “SHISHIMAI (Dance)” OR DE “SQUARE dancing” OR
DE “STEP dancing” OR DE “TANGO (Dance)” OR DE “TAP dancing”
S24DE “PHYSICAL training& conditioning”ORDE “ACROBATICS -- Training”ORDE “ALTITUDE training”ORDE “ANAER-
OBIC training” OR DE “ARCHERY -- Training” OR DE “BADMINTON (Game) -- Training” OR DE “BASE training (Exercise)”
OR DE “BASEBALL -- Training” OR DE “BASKETBALL -- Training” OR DE “BICYCLE racing -- Training” OR DE “BODY-
BUILDING -- Training” OR DE “BOWLING -- Training” OR DE “BOXING -- Training” OR DE “BULLFIGHT training &
conditioning” ORDE “BUNGEE jumping training & conditioning” ORDE “CANOES& canoeing -- Training” ORDE “CAVING
training & conditioning” OR DE “COMPOUND exercises” OR DE “CONTRAST training (Physical training & conditioning)”
OR DE “COXSWAINING -- Training” OR DE “CRICKET training & conditioning” OR DE “CROSS-training (Sports)” OR
DE “CYCLING -- Training” OR DE “DANCE training & conditioning” OR DE “DEEP diving training & conditioning” OR DE
“DIVING -- Training” OR DE “DOGSLEDDING training & conditioning” OR DE “ENDURANCE sports -- Training” OR DE
“FENCING -- Training” OR DE “FIELD hockey training & conditioning” OR DE “FOOTBALL -- Training” OR DE “FUNC-
TIONAL training” OR DE “GLIDING & soaring training & conditioning” OR DE “GOLF -- Training” OR DE “GYMNASTICS
-- Training” OR DE “HANDBALL training & conditioning” OR DE “HIKING training & conditioning” OR DE “HOCKEY --
Training” OR DE “HUNTING training & conditioning” OR DE “INTERVAL training” OR DE “ISOLATION exercises” OR DE
“KAYAKING -- Training” OR DE “KNIFE fighting -- Training” OR DE “KORFBALL -- Training” OR DE “LACROSSE training
& conditioning” OR DE “LONG slow distance training” OR DE “MARTIAL arts -- Training” OR DE “MOTORSPORTS training
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& conditioning” OR DE “MOUNTAINEERING -- Training” OR DE “NUNCHAKU -- Training” OR DE “ORIENTEERING -
- Training” OR DE “OVERTRAINING” OR DE “PACE training” OR DE “PARACHUTING training & conditioning” OR DE
“PARAKITING training & conditioning” OR DE “PERIODIZATION training” OR DE “PERSONAL training” OR DE “POLO
training & conditioning” OR DE “PRACTICE (Sports)” OR DE “PRESEASON (Sports)” OR DE “RACQUETBALL -- Training”
OR DE “RECOVERY training” OR DE “RELAY racing -- Training” OR DE “REPETITION training” OR DE “RESISTANCE
training (Physical training & conditioning)” OR DE “ROCK climbing -- Training” OR DE “RODEO training & conditioning”
OR DE “ROLLER skating training & conditioning” OR DE “ROWING -- Training” OR DE “RUGBY football -- Training” OR
DE “RUNNING -- Training” OR DE “SHOT putting -- Training” OR DE “SKATING -- Training” OR DE “SKIS & skiing --
Training” OR DE “SKYDIVING training & conditioning” OR DE “SOCCER -- Training” OR DE “SOFTBALL -- Training” OR
DE “SPEED endurance training” OR DE “SQUASH (Game) -- Training” OR DE “STRENGTH training” OR DE “SURFING --
Training” ORDE “SWIMMING -- Training” ORDE “TABLE tennis training & conditioning” ORDE “TEAM handball -- Training”
OR DE “TENNIS -- Training” OR DE “TRACK & field -- Training” OR DE “TRIATHLON -- Training” OR DE “TUG of war
(Game) -- Training” OR DE “VAULTING (Horsemanship) -- Training” OR DE “VOLLEYBALL -- Training” OR DE “WATER
polo -- Training” OR DE “WEIGHT training” OR DE “WHEELCHAIR sports -- Training” OR DE “WINTER sports training &
conditioning” OR DE “WRESTLING -- Training” OR DE “YOGA training & conditioning”
S23 DE “BALL games” OR DE “ANETSO” OR DE “BALL hockey” OR DE “BALLE au tamis (Game)” OR DE “BASEBALL” OR
DE “BASKETBALL” OR DE “BATTLE ball” OR DE “BICYCLE polo” OR DE “BILLIARDS” OR DE “BOWLING games” OR
DE “BROOMBALL” ORDE “CAMOGIE (Game)” OR DE “CRICKET (Sport)” ORDE “CROQUET” OR DE “DODGEBALL”
ORDE “FIELD hockey” ORDE “FLICKERBALL” ORDE “FOOTBALL” ORDE “GOAL ball” ORDE “GOLF” ORDE “GOLF
croquet” OR DE “HANDBALL” OR DE “HURLING (Game)” OR DE “INDOOR hockey” OR DE “JAPANESE polo” OR DE
“JIAN zi (Game)” OR DE “KANG (Game)” OR DE “KICKBALL” OR DE “LACROSSE” OR DE “LAPTA (Game)” OR DE
“LAWN tempest (Game)” OR DE “MINTON (Game)” OR DE “PARLOR football” OR DE “PARLOR tennis” OR DE “PICKLE
ball” OR DE “PICKLEBALL (Game)” OR DE “PIZE-ball” OR DE “POLO” OR DE “POLOCROSSE” OR DE “PUSH ball” OR
DE “QUIDDITCH (Game)” OR DE “RACQUETBALL” OR DE “RAGA (Game)” OR DE “ROLL ball” OR DE “ROUNDERS”
OR DE “RUGBALL” OR DE “SCHLAGBALL” OR DE “SHINTY (Game)” OR DE “SOCCER” OR DE “SOFTBALL” OR DE
“SPEED-a-way (Game)” OR DE “SPEEDBALL” OR DE “STICKBALL (Game)” OR DE “STOOLBALL” OR DE “TABLE tennis”
OR DE “TCHOUKBALL” ORDE “TENNIS” OR DE “TETHERBALL” ORDE “TRAPBALL” ORDE “VOLLEYBALL” OR DE
“WALLYBALL” OR DE “WATER polo” OR DE “WICKET” OR DE “WIFFLE ball”
S22 DE “EXERCISE tolerance”
S21 DE “PHYSICAL fitness” ORDE “ANAEROBIC exercises” ORDE “ASTROLOGY & physical fitness” ORDE “BODYBUILD-
ING” OR DE “CARDIOVASCULAR fitness” OR DE “CIRCUIT training” OR DE “COMPOUND exercises” OR DE “ISOLA-
TION exercises” ORDE “LIANGONG” ORDE “MUSCLE strength” OR DE “PERIODIZATION training” ORDE “PHYSICAL
fitness -- Genetic aspects” ORDE “PHYSICAL fitness for children” ORDE “PHYSICAL fitness for girls” ORDE “PHYSICAL fitness
for men” ORDE “PHYSICAL fitness for older people” OR DE “PHYSICAL fitness for people with disabilities” OR DE “PHYSICAL
fitness for women” OR DE “PHYSICAL fitness for youth” OR DE “SPORT for All”
S20 DE “EXERCISE” OR DE “ABDOMINAL exercises” OR DE “AEROBIC exercises” OR DE “ANAEROBIC exercises” OR DE
“AQUATIC exercises” OR DE “ARM exercises” OR DE “BACK exercises” OR DE “BREATHING exercises” OR DE “BREEMA”
OR DE “BUTTOCKS exercises” OR DE “CALISTHENICS” OR DE “CHAIR exercises” OR DE “CHEST exercises” OR DE
“CIRCUIT training” OR DE “COMPOUND exercises” OR DE “DO-in” OR DE “EXERCISE -- Immunological aspects” OR DE
“EXERCISE adherence” OR DE “EXERCISE for children” OR DE “EXERCISE for girls” OR DE “EXERCISE for men” OR DE
“EXERCISE for middle-aged persons” OR DE “EXERCISE for older people” OR DE “EXERCISE for people with disabilities” OR
DE “EXERCISE for women” OR DE “EXERCISE for youth” OR DE “EXERCISE therapy” OR DE “EXERCISE video games” OR
DE “FACIAL exercises” OR DE “FALUN gong exercises” OR DE “FOOT exercises” OR DE “GYMNASTICS” OR DE “HAND
exercises” ORDE “HATHA yoga” ORDE “HIP exercises” ORDE “ISOKINETIC exercise”ORDE “ISOLATION exercises” ORDE
“ISOMETRIC exercise” OR DE “ISOTONIC exercise” OR DE “KNEE exercises” OR DE “LEG exercises” OR DE “LIANGONG”
OR DE “METABOLIC equivalent” OR DE “MULAN quan” OR DE “MUSCLE strength” OR DE “PILATES method” OR DE
“PLYOMETRICS” OR DE “QI gong” OR DE “REDUCING exercises” OR DE “RUNNING” OR DE “RUNNING -- Social
aspects” OR DE “SCHOOLS -- Exercises & recreations” OR DE “SEXUAL exercises” OR DE “SHOULDER exercises” OR DE
“STRENGTH training” OR DE “STRESS management exercises” OR DE “STRETCHING exercises” OR DE “TAI chi” OR DE
“TREADMILL exercise” OR DE “WHEELCHAIR workouts” OR DE “YOGA”
S19 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR
S17 OR S18
S18 TI ( ari or urti or lrti ) OR AB ( ari or urti or lrti )
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S17 TI ( bronchit* or pneumon* or bronchopneumon* or pleuropneumon* ) OR AB ( bronchit* or pneumon* or bronchopneumon*
or pleuropneumon* )
S16 TI ( sinusit* or rhinosinusit* or nasosinusit* ) OR AB ( sinusit* or rhinosinusit* or nasosinusit* )
S15 TI cough* OR AB cough*
S14 TI ( nasopharyngit* or rhinopharyngit* ) OR AB ( nasopharyngit* or rhinopharyngit* )
S13 TI ( throat* N3 (infect* or inflam*) ) OR AB ( throat* N3 (infect* or inflam*) )
S12 TI ( pharyngit* or laryngit* or tonsillit* or sore throat* ) OR AB ( pharyngit* or laryngit* or tonsillit* or sore thoat* )
S11 TI ( influenza* or flu or ili ) OR AB ( influenza* or flu or ili )
S10 TI ( (acute or viral or virus* or bacter*) N2 rhinit* ) OR AB ( (acute or viral or virus* or bacter*) N2 rhinit* )
S9 TI ( common cold* or colds or coryza ) OR AB ( common cold* or colds or coryza )
S8 TI ( respiratory N2 (infect* or illness or symptom* or acute or virus*) ) OR AB ( respiratory N2 (infect* or illness or symptom* or
acute or virus*) )
S7 DE “BRONCHITIS”
S6 DE “COUGH”
S5 DE “PNEUMONIA”
S4 DE “SINUSITIS”
S3 DE “INFLUENZA”
S2 DE “COLD (Disease)”
S1 DE “RESPIRATORY infections”
C O N T R I B U T I O N S O F A U T H O R S
Antonio Jose Grande: co-ordinated retrieval of papers and wrote the background, methods, results, discussion and conclusion.
Hamish Reid: participated in retrieval of papers, quality assessment and co-wrote the background, methods, results, discussion and
conclusion.
Emma Thomas: participated in retrieval of papers, quality assessment and co-wrote the background, methods, results, discussion and
conclusion.
David Nunan: co-wrote the background, methods, results, discussion and conclusion.
Charles Foster: co-wrote the background, methods, results, discussion and conclusion.
D E C L A R A T I O N S O F I N T E R E S T
Antonio Jose Grande: none known
Hamish Reid: none known
Emma E Thomas: none known
David Nunan: I have received funding from the NIHR School for Primary Care Research for a project related to physical activity
Charles Foster: none known.
43Exercise prior to influenza vaccination for limiting influenza incidence and its related complications in adults (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
S O U R C E S O F S U P P O R T
Internal sources
• CF is funded by BHF core grant 021/P&C/core/2010/HPRG, UK.
• AJG is a recipient of a Postdoctoral Scholarship from Science Without Borders - Cnpq, Brazil.
• DN has received funding from the NIHR School of Primary Care Research, UK.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added subset analysis to assess vaccination timing because we felt it was important to distinguish if vaccination was administered
immediately after exercise or some time before vaccination. We deleted the comparison ’Exercise with influenza vaccination versus
exercise with placebo vaccination’ from the review, since this outcome was not addressed in studies.
We deleted a secondary outcome proposed in our protocol: ’Exercise compliance rates of participants’. We made this exclusion because
it was not an outcome of the intervention.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Exercise; ∗Vaccination; Incidence; Influenza Vaccines [∗administration & dosage; adverse effects]; Influenza, Human [complications;
epidemiology; ∗prevention & control]; Randomized Controlled Trials as Topic; Resistance Training [methods]; Time Factors; Walking
MeSH check words
Adult; Aged; Aged, 80 and over; Humans; Middle Aged
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